Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Signing Ceremony of the "PARAMED Project"

 
Signing Ceremony of the "PARAMED Project": A Vital Reinforcement of the Public Health Sector in Lebanon
 

Under the patronage of H.E. Dr. Firass El Abiad, Mnister of Public Health, and in the presence of a delegation from the French Ministry of Health, an official signing ceremony for the "Project for Supporting the Healthcare Personnel Skills in the Public Sector in Lebanon (PARAMED)" took place in the conference room of the Ministry of Public Health (MOPH) in Jnah.  .

This project, co-financed by Agence Française de Developpement (AFD) and the IF! Foundation, and implemented by the European Institute for Cooperation and Development (IECD), aims to substantially strengthen the skills of healthcare professionals within Lebanon's public health structures.

In his speech, the Minister of Public Health, Dr. Firas El Abiad, emphasized: "The importance of this program lies in its expansion to include 12 public hospitals, after initially starting with four hospitals, with the aim of training healthcare professionals so they can provide the necessary services to our citizens, especially the most vulnerable segments of Lebanese society. This program is funded by the French Development Agency to the tune of six million euros and is implemented by the European Institute for Cooperation and Development in Lebanon." Minister Abiad continued by stating that: “This program would not have been possible without the support provided by France to Lebanon, particularly through the French Development Agency (AFD), which supports several projects in the health and education sectors. What is remarkable about this program is that it brings together the health and education sectors, with the goal of providing better healthcare services to all people on Lebanese territory.”

Mrs. Catherine Bonnaud, Country Director and Regional Director of AFD, declared that by investing in training and professional development of health workers, we strengthen not only individual capabilities, but also the resilience and effectiveness of the health system as a whole. This is a long-term investment in the health and well-being of all Lebanese citizens.

In a context of crisis affecting the Lebanese healthcare system, the PARAMED project represents a crucial initiative to improve the quality of care provided to the most vulnerable populations and facilitate access to it. The project includes, among other objectives, the establishment of training centers in 12 public hospitals and the implementation of ongoing training and refresher programs for recent graduates and existing hospital staff.
 
Mr. Vianney Basse, Director for Lebanon and the Middle East at IECD, emphasized the quality of the trust-based relationship between the Minister of Health, AFD, and IECD, and that this partnership is fully aligned with the Ministry’s 2030 Strategy. He recalled that IECD, whose mission is to support youth through vocational training projects, will strengthen its involvement in the health sector through PARAMED.

By strengthening the capacities of health professionals and promoting the employability of young men and women in the field of nursing, the PARAMED project aims to reach 4,200 healthcare workers and approximately 3 million patients. In doing so, it will help reduce gaps and improve the quality of healthcare in Lebanon.
    4
    ...
ATC Name B/G Ingredients Dosage Form Price
L01FC01 DARZALEX BioTech Daratumumab - 400mg/20ml 400mg/20ml Injectable concentrate for solution 143,582,703 L.L
C01CA07 DOBUTAMINE PANPHARMA G Dobutamine (HCl) - 250mg/20ml 250mg/20ml Injectable concentrated solution 2,701,123 L.L
L01DB01 DOXORUBICINE EBEWE G Doxorubicin HCl - 10mg/5ml 10mg/5ml Injectable concentrated solution 428,686 L.L
L01DB01 DOXORUBICINE EBEWE G Doxorubicin HCl - 2mg/ml 50mg/25ml Injectable concentrated solution 1,804,780 L.L
L01DB01 DOXORUBICINE EBEWE G Doxorubicin HCl - 2mg/ml 50mg/25ml Injectable concentrated solution L.L
B05XB02 DIPEPTIVEN B L-alanine-L-Glutamine - 20g/100ml 20g/100ml Injectable concentrated solution 2,940,456 L.L
C01CA04 DOPAMINE FRESENIUS G Dopamine HCl - 200mg/5ml 200mg/5ml Injectable concentrated solution 713,580 L.L
C01CA04 DOPAMINE RENAUDIN G Dopamine HCl - 200mg/5ml 4% Injectable concentrated solution 1,107,326 L.L
L01CD02 DOCETAXEL GP PHARM G Docetaxel - 80mg/2ml 80mg/2ml Injectable concentrated solution+diluent 16,777,239 L.L
L01CD02 DOCETAXEL GP PHARM G Docetaxel - 20mg/0.5ml 20mg/0.5ml Injectable concentrated solution+diluent 4,567,721 L.L
N01AX10 DORMIFOR G Propofol - 1% 1% Injectable emulsion 1,081,473 L.L
L01BC08 DACOGEN B Decitabine - 50mg 50mg Injectable lyophilised powder for solution 90,496,389 L.L
L01BC08 DACOGEN B Decitabine - 50mg 50mg Injectable lyophilised powder for solution 90,495,926 L.L
L02AE04 DECAPEPTYL B Triptorelin - 0.1mg 0.1mg Injectable lyophilised powder for solution+diluent 2,366,507 L.L
N03AG01 DEPAKINE B Sodium Valproate - 400mg 400mg Injectable lyophilised powder for solution+diluent 450,187 L.L
B03BA51 DEPOVEX B Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml Injectable oily suspension 423,310 L.L
M03AX01 DYSPORT BioTech Clostridium botulinum type A neurotoxin complex - 300units 300units Injectable powder for solution 14,625,182 L.L
M03AX01 DYSPORT BioTech Clostridium botulinum type A neurotoxin complex - 500units 500units Injectable powder for solution 42,726,155 L.L
L01AX04 DACARBAZINE MEDAC G Dacarbazine - 200mg 200mg Injectable powder for solution 15,866,076 L.L
L01AX04 DACARBAZINE MEDAC G Dacarbazine - 1,000mg 1,000mg Injectable powder for solution 5,411,654 L.L
L02AE04 DECAPEPTYL SR B Triptorelin (pamoate) - 3mg 3mg Injectable powder for suspension+diluent L.L
L02AE04 DECAPEPTYL SR B Triptorelin (pamoate) - 3mg 3mg Injectable powder for suspension+diluent 11,778,312 L.L
L02AE04 DECAPEPTYL SR B Triptorelin (pamoate) - 11.25mg 11.25mg Injectable powder for suspension+diluent 31,761,098 L.L
B05BB02 DEXTROSE 2.5% & SODIUM CHLORIDE 0.45% G Sodium chloride - 0.45g/100ml, Dextrose, H2O - 2.5g/100ml Injectable solution 212,598 L.L
B05BB02 DEXTROSE 2.5% SODIUM CHLORIDE 0.45% INJECTION, USP G Sodium chloride - 0.45%, Glucose - 2.5% Injectable solution 185,018 L.L
B05BB02 DEXTROSE 2.5% SODIUM CHLORIDE 0.45% INJECTION, USP G Sodium chloride - 0.45%, Glucose - 2.5% Injectable solution 174,675 L.L
B05BB02 DEXTROSE 2.5% SODIUM CHLORIDE 0.45% INJECTION, USP G Sodium chloride - 0.45%, Glucose - 2.5% Injectable solution 148,566 L.L
B05BB02 DEXTROSE 5% IN LACTATED RINGER'S G Sodium lactate - 0.31g/100ml, Calcium chloride 2H2O - 0.02g/100ml, Potassium chloride - 0.03g/100ml, Sodium chloride - 0.598g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 207,404 L.L
B05BB02 DEXTROSE 5% & SODIUM CHLORIDE 0.2% G Sodium chloride - 0.2g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 194,165 L.L
B05BB02 DEXTROSE 5% & SODIUM CHLORIDE 0.2% G Sodium chloride - 0.2g/100ml, Dextrose, H2O - 5g/100ml Injectable solution 220,643 L.L
    4
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026